Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP8302 in Underactive Bladder
NCT03702777Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial in underactive bladder (UAB) comparing ASP8302 with Placebo (2 arms). Primary endpoint: Change From Baseline in Post-Void Residual After Standardized Bladder Filling Measured by Catheterization at Week 4. Started Nov 2018; status: completed.
02
Drugs
ASP8302
03
Conditions
underactive bladder (UAB)
Beyond the preview
Go deeper on NCT03702777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03702777.